MAPT and Atrophy: Another hypothesis for the mismatch is that tau pathology occurs later in the disease course in the midbrain in PSP-SL and due to the presumed lag between tau deposition and subsequent atrophy, midbrain volume has not decreased to the level observed in PSP-RS.